Johnson & Johnson, Kenvue Inc. to Pay $45M in US Cancer Case

Johnson & Johnson, Kenvue Inc. to Pay $45M in US Cancer Case

April 22, 2024 : In a recent legal development with significant implications for the litigation surrounding talcum powder and cancer risk, a jury in Illinois ruled against Johnson & Johnson and its subsidiary, Kenvue Inc. The jury awarded $45 million to the family of Theresa Garcia, who passed away in 2020 from mesothelioma, a rare form of cancer.

The lawsuit, filed by Garcia’s family, alleged that her mesothelioma was caused by her long-term use of talcum powder products manufactured by Johnson & Johnson. The plaintiffs specifically contended that the talcum powder contained asbestos fibers, a known carcinogen linked to mesothelioma development.

Attorneys representing Garcia’s family further argued that Johnson & Johnson and Kenvue Inc. knew the potential health risks associated with asbestos contamination in talcum powder but failed to adequately warn consumers. The jury’s verdict appears to support these claims.

This case represents the first verdict against Kenvue Inc., which Johnson & Johnson spun off in 2021. However, Johnson & Johnson has faced numerous similar lawsuits recently. Thousands of women have alleged that their use of talcum powder products led to the development of ovarian cancer. The company has consistently denied these allegations, maintaining that its talcum powder products are safe.

The $45 million verdict is a significant setback for Johnson & Johnson and Kenvue Inc. It adds to the mounting financial burden of the ongoing talcum powder litigation. The verdict will also likely encourage other plaintiffs with similar claims to pursue legal action against these companies.

While this verdict represents a legal victory for Garcia’s family, it is important to note that it does not necessarily establish a definitive link between talcum powder use and mesothelioma. Further scientific research and legal proceedings are required to definitively determine the extent to which, if any, talcum powder contributes to the development of this type of cancer.

The Johnson & Johnson and Kenvue Inc. legal teams have indicated their intention to appeal the jury’s verdict. This legal battle will likely continue for some time, with potentially far-reaching implications for the talcum powder industry and the ongoing debate surrounding product safety and consumer information.


Also Read, AI Discovers New Parkinson’s Disease Treatments